Skip to main content
. 2021 Mar 2;13(3):824. doi: 10.3390/nu13030824

Table 3.

Hippocampal oxylipin concentration of mice fed orally with control solution, fish hydrolysate or DHA by daily gavage for 18 days, 2 h following LPS injection (125 µg/kg).

Oxylipin (pg /mg protein) Control Hydrolysate DHA Statistical Effect
Saline LPS Saline LPS Saline LPS Supplementation LPS Supplementation × LPS
AA-oxylipins
Thromboxanes, prostaglandins
TxB2 1584.36 ± 136.93 1739.60 ± 138.94 1729.72 ± 220.19 1495.16 ± 30.78 1781.36 ± 166.54 1747.47 ± 205.07 - - -
6kPGF1α 151.68 ± 68.79 a 505.96 ± 66.67 b 246.65 ± 83.26 a 78.59 ± 49.27 a 210.93 ± 69.00 a 226.75 ± 92.39 a - - p = 0.0086
PGF2α 4429.79 ± 380.97 5550.45 ± 330.52 4582.04 ± 486.14 5708.87 ± 577.25 5656.33 ± 461.46 5155.75 ± 727.26 - - -
PGE2 1428.02 ± 141.17 a 2366.55 ± 121.53 b 1410.87 ± 117.93 a 2356.64 ± 224.38 b 1883.66 ± 204.02 a,b 1881.02 ± 257.90 a,b - p = 0.0003 p = 0.0211
PGD2 1741.08 ± 319.14 a 3208.60 ± 445.99 b 1639.05 ± 216.33 a 3188.42 ± 282.95 b,c 2301.83 ± 244.21 a,b 2178.11 ± 411.06 a,c - p = 0.002 p = 0.0314
PGA1 0.00 ± 0.00 a 28.65 ± 7.78 b 0.00 ± 0.00 a 34.75 ± 11.80 b 0.00 ± 0.00 a 0.00 ± 0.00 a p = 0.0014 p < 0.0001 p = 0.0014
15dPGJ2 31.15 ± 19.37 71.23 ± 8.44 13.59 ± 13.59 89.69 ± 19.08 45.69 ± 23.73 53.66 ± 24.59 - p = 0.0145 -
8isoPGA2 464.81 ± 24.87 651.95 ± 76.86 500.41 ± 109.57 864.62 ± 133.33 682.20 ± 116.56 750.64 ± 92.68 - p = 0.0184 -
Lipoxins
LxA4 265.31 ± 31.85 a 764.10 ± 117.00 c 352.61 ± 37.66 a,b 1126.31 ± 115.00 d 631.05 ± 121.16 b,c 614.25 ± 151.20 b,c - p < 0.0001 p = 0.0041
LxB4 119.60 ± 79.81 413.04 ± 100.91 488.09 ± 79.65 560.64 ± 67.12 342.60 ± 115.89 309.99 ± 112.83 p = 0.0483 - -
Epoxy fatty acids
14,15-EET 258.15 ± 55.32 218.68 ± 27.43 221.62 ± 44.03 339.82 ± 95.94 317.46 ± 68.49 321.12 ± 36.59 - - -
8,9-EET 665.74 ± 86.14 717.35 ± 62.99 745.55 ± 88.82 1132.12 ± 251.53 984.20 ± 127.64 904.92 ± 119.39 - - -
5,6-EET 510.40 ± 59.39 552.36 ± 22.88 607.26 ± 61.65 776.15 ± 152.98 730.88 ± 94.28 687.14 ± 90.15 - - -
Hydroxy fatty acids
15-HETE 5381.63 ± 491.85 a 10236.55 ± 1133.60 b,c 4986.08 ± 394. 85 a 12370.92 ± 946.68 c 8412.97 ± 1033.41 b 8271.61 ± 1124.26 b - p < 0.0001 p = 0.0014
8-HETE 616.39 ± 59.62 a 861.88 ± 71.18 b 536.21 ± 32.63 a 1094.93 ± 100.61 c 825.45 ± 81.77 b 823.81 ± 84.78 b - p = 0.0001 p = 0.0033
12-HETE 1496.97 ± 53.35 a,b 2662.28 ± 394.98 c,d 1188.01 ± 51.49 a 3479.62 ± 252.58 d 2076.89 ± 258.48 b,c 2145.92 ± 439.72 b,c - p < 0.0001 p = 0.0044
5-HETE 5518.82 ± 671.54 6747.00 ± 403.13 5484.87 ± 486.33 8002.11 ± 382.00 7715.60 ± 1005.41 8939.82 ± 1212.00 p = 0.0318 p = 0.0262 -
5-oxoETE 5524.57 ± 639.67 a 6300.15 ± 474.39 a,c 5286.41 ± 199.95 a 9143.13 ± 785.06 b 8623.43 ± 291.86 b 7449.52 ± 981.74 b,c p = 0.0072 p = 0.0342 p = 0.0022
LA-oxylipins
Hydroxy fatty acids
13-HODE 1294.54 ± 41.33 a 2091.36 ± 184.04 a 1429.20 ± 192.49 a 3655.32 ± 871.76 b 2266.32 ± 315.64 a 2212.73 ± 339.80 a - p = 0.0026 p = 0.0134
9-HODE 497.38 ± 19.99 a 979.03 ± 109.81 b,c 577.19 ± 76.69 a,b 1628.82 ± 355.30 d 967.76 ± 132.13 b,c 950.78 ± 147.61 a,c - p = 0.0005 p = 0.0066
DHA-oxylipins
Hydroxy fatty acids
17-HDoHE 1208.83 ± 91.11 a,b 2030.94 ± 216.72 c,d 1002.70 ± 83.64 b 2428.07 ± 154.48 c 1717.12 ± 318.00 a,d 1731.76 ± 194.06 a,d - p = 0.0001 p = 0.0076
14-HDoHE 819.92 ± 71.54 a,b 1171.61 ± 168.81 b,c 639.76 ± 45.18 a 1683.52 ± 143.81 d 1266.36 ± 167.27 c,d 1290.20 ± 175.01 c,d - p = 0.0004 p = 0.0056
7-MaR1 0.00 ± 0.00 a,b 42.73 ± 11.82 b 0.00 ± 0.00 a 88.89 ± 50.81 c 0.00 ± 0.00a 0.00 ± 0.00a p = 0.0289 p = 0.0019 p = 0.0289

Values with superscripts (a, b, c, d) differ significantly, n = 4–6/group. Data are presented as mean ± SEM and are expressed in pg/mg protein. 5-oxoETE: 5-oxo-eicosatetraenoic; 7-MaR1: 7(S)-maresin; AA: arachidonic acid; DHA: docosahexaenoic acid; EET: epoxy-eicosatrienoic acid; HDoHE: hydroxy-docosahexaenoic acid; HETE: hydroxy-eicosatetraenoic acid; HODE: hydroxy-octadecadienoic acid; LA: linoleic acid; LPS: lipopolysaccharide; Lx: lipoxin; PG: prostaglandin; TxB2: thromboxane B2.